Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 629367, 6 pages
http://dx.doi.org/10.1155/2015/629367
Research Article

Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion

1Department of Biochemistry, Faculty of Science, Mahidol University, 272 Rama VI Road, Bangkok 10400, Thailand
2Proteomics Research Laboratory, Genome Institute, National Science and Technology Development Agency, 111 Thailand Science Park, Phahonyothin Road, Pathum Thani 12120, Thailand

Received 7 November 2014; Accepted 9 March 2015

Academic Editor: Joy Scaria

Copyright © 2015 Kasima Wasuworawong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Sripa, S. Kaewkes, P. Sithithaworn et al., “Liver fluke induces cholangiocarcinoma,” PLoS medicine, vol. 4, no. 7, article e201, 2007. View at Google Scholar · View at Scopus
  2. A. F. Chambers, A. C. Groom, and I. C. MacDonald, “Dissemination and growth of cancer cells in metastatic sites,” Nature Reviews Cancer, vol. 2, no. 8, pp. 563–572, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation,” Cell, vol. 144, no. 5, pp. 646–674, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. W. G. Stetler-Stevenson, “Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention,” Journal of Clinical Investigation, vol. 103, no. 9, pp. 1237–1241, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. C. D. Anderson, C. W. Pinson, J. Berlin, and R. S. Chari, “Diagnosis and treatment of cholangiocarcinoma,” Oncologist, vol. 9, no. 1, pp. 43–57, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. G. J. Gores, “Cholangiocarcinoma: current concepts and insights,” Hepatology, vol. 37, no. 5, pp. 961–969, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. E. Sirica, “Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy,” Hepatology, vol. 41, no. 1, pp. 5–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Sripa, S. Leungwattanawanit, T. Nitta et al., “Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100),” World Journal of Gastroenterology, vol. 11, no. 22, pp. 3392–3397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. R. Piersma, M. O. Warmoes, M. de Wit, I. de Reus, J. C. Knol, and C. R. Jiménez, “Whole gel processing procedure for GeLC-MS/MS based proteomics,” Proteome Science, vol. 11, no. 1, article 17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Albini, Y. Iwamoto, and H. K. Kleinman, “A rapid in vitro assay for quantitating the invasive potential of tumor cells,” Cancer Research, vol. 47, no. 12, pp. 3239–3245, 1987. View at Google Scholar · View at Scopus
  11. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  12. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Ratthaphol, K. Imtawil, S. Wongkham, and C. Wongkham, “Development of homemade cholangiocarcinoma DNA array,” Srinagarind Medical Journal, pp. 203–205, 2007. View at Google Scholar
  14. I. Salama, P. S. Malone, F. Mihaimeed, and J. L. Jones, “A review of the S100 proteins in cancer,” European Journal of Surgical Oncology, vol. 34, no. 4, pp. 357–364, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Wolf, C. Haase-Kohn, and J. Pietzsch, “S100A2 in cancerogenesis: a friend or a foe?” Amino Acids, vol. 41, no. 4, pp. 849–861, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. K. Mishra, H. R. Siddique, and M. Saleem, “S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence,” Cancer and Metastasis Reviews, vol. 31, no. 1-2, pp. 163–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Lukanidin and J. P. Sleeman, “Building the niche: the role of the S100 proteins in metastatic growth,” Seminars in Cancer Biology, vol. 22, no. 3, pp. 216–225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Bulk, B. Sargin, U. Krug et al., “S100A2 induces metastasis in non-small cell lung cancer,” Clinical Cancer Research, vol. 15, no. 1, pp. 22–29, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Yao, A. Lopez-Beltran, G. T. Maclennan, R. Montironi, J. N. Eble, and L. Cheng, “Expression of S100 protein family members in the pathogenesis of bladder tumors,” Anticancer Research, vol. 27, no. 5, pp. 3051–3058, 2007. View at Google Scholar · View at Scopus
  20. H.-L. Hsieh, B. W. Schäfer, N. Sasaki, and C. W. Heizmann, “Expression analysis of S100 proteins and RAGE in human tumors using tissue microarrays,” Biochemical and Biophysical Research Communications, vol. 307, no. 2, pp. 375–381, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. C. D. Hough, K. R. Cho, A. B. Zonderman, D. R. Schwartz, and P. J. Morin, “Coordinately up-regulated genes in ovarian cancer,” Cancer Research, vol. 61, no. 10, pp. 3869–3876, 2001. View at Google Scholar · View at Scopus
  22. D. B. Villaret, T. Wang, D. Dillon et al., “Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis,” Laryngoscope, vol. 110, no. 3, part 1, pp. 374–381, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Naz, P. Ranganathan, P. Bodapati, A. H. Shastry, L. N. Mishra, and P. Kondaiah, “Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion,” Biochemical Journal, vol. 447, no. 1, pp. 81–91, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Naz, M. Bashir, P. Ranganathan, P. Bodapati, V. Santosh, and P. Kondaiah, “Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3,” Carcinogenesis, vol. 35, no. 1, pp. 14–23, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Muelleri, B. W. Schäfer, S. Ferrari et al., “The Calcium-binding protein S100A2 interacts with p53 and modulates its transcriptional activity,” The Journal of Biological Chemistry, vol. 280, no. 32, pp. 29186–29193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Sato, K. Harada, M. Sasaki, and Y. Nakanuma, “Clinicopathological significance of S100 protein expression in cholangiocarcinoma,” Journal of Gastroenterology and Hepatology, vol. 28, no. 8, pp. 1422–1429, 2013. View at Publisher · View at Google Scholar · View at Scopus